Epicore BioNetworks Inc. Announces Personnel Changes

Aug 09, 2013, 17:05 ET from Epicore BioNetworks Inc.

CALGARY, Aug. 9, 2013 /PRNewswire/ - The Management of Epicore BioNetworks Inc. is pleased to announce two important personnel changes that will help position the Company for continued business growth.

Mr. Fernando Garcia, Epicore's Aquaculture Business Development Director, has relocated from Guayaquil, Ecuador to Eastampton, New Jersey.  Fernando was instrumental in the formation of Epicore's Ecuadorian subsidiary and has been a cornerstone of its worldwide aquaculture business. With the increasingly important challenges and opportunities in Epicore's business outside Ecuador, the Company decided several years ago that Fernando would be even more effective operating out of its Eastampton business center.  Fernando and Family relocated to New Jersey this summer.

Management is pleased to announce that Mr. Fabrizzio Vanoni has been promoted to Latin American Sales Manager, reporting to Mr. Garcia.  Fabrizzio has worked for Epicore Ecuador S.A. in various technical and sales positions since 2004.  He studied aquaculture technology at the Espromed Technical Institute in Guayaquil and owns a very successful 100 hectare shrimp farm.  In addition to his Ecuadorian responsibilities, Fabrizzio has provided technical and sales support to our Mexican distributor.  In his new role, his sales management responsibilities will expand to cover all of Latin America.

Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products.  It manufactures in the USA and markets worldwide to a variety of industries to reduce environmental pollution and increase operational productivity.

Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN).  [The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.]

SOURCE Epicore BioNetworks Inc.